Drugs in Australia 2010: tobacco, alcohol and other drugs

Publication

•  Drugs in Australia 2010: tobacco, alcohol and other drugs (3.1MB PDF)
• Drugs in Australia 2010: tobacco, alcohol and other drugs (6.9MB RTF)

Publication table of contents

• Preliminary material
  • Title and verso pages
  • Contents
  • Acknowledgments
  • Abbreviations
  • Symbols
  • Summary
    • Patterns of drug use
      • Tobacco and alcohol
      • Illicit drugs
    • Services related to drug use or treatment
      • Substance use—specific services
      • Other services
    • Vulnerable groups
    • Drugs and crime
• Body section
  • 1 Introduction
    • 1.1 Data sources
  • 2 Tobacco
    • 2.1 Key findings
    • 2.2 Introduction
    • 2.3 Attitudes and opportunity to use
    • 2.4 Reported consumption
      • 2.4.1 Trends
      • 2.4.2 Age and sex
      • 2.4.3 Younger people and school students
      • 2.4.4 Aboriginal and Torres Strait Islander people
      • 2.4.5 Socioeconomic status
      • 2.4.6 Other social characteristics
    • 2.5 Cessation attempts
    • 2.6 Apparent consumption
    • 2.7 Tobacco-related costs, revenue and expenditure
    • 2.8 State, territory and international comparisons
      • 2.8.1 State and territory comparisons
      • 2.8.2 International comparisons
    • 2.9 Health and harms
      • 2.9.1 Health of smokers
      • 2.9.2 Second-hand smoke
        • In the home
        • In the workplace
      • 2.9.3 Social issues associated with smoking
  • 3 Alcohol
    • 3.1 Key findings
    • 3.2 Introduction
    • 3.3 Attitudes and opportunity to use
    • 3.4 Reported consumption
      • 3.4.1 Trends
      • 3.4.2 Age and sex
      • 3.4.3 Risk levels
        • Risk of alcohol-related harm from a single drinking occasion
        • Risk of alcohol-related harm over a lifetime
      • 3.4.4 Social characteristics
    • 3.5 Apparent consumption
    • 3.6 Alcohol-related costs, revenue and expenditure
    • 3.7 Polydrug use
    • 3.8 Reduction and cessation of consumption
    • 3.9 State, territory and international comparisons
      • 3.9.1 State and territory comparisons
      • 3.9.2 International comparisons
    • 3.10 Health and harms
      • 3.10.1 Mental health
      • 3.10.2 Social harms
  • 4 Illicit drugs overview
    • 4.1 Key findings
    • 4.2 Introduction
    • 4.3 Attitudes
    • 4.4 Consumption
      • 4.4.1 Age and sex
      • 4.4.2 Trends
      • 4.4.3 Concurrent drug use
    • 4.5 International comparisons
    • 4.6 Costs and expenditure
    • 4.7 Health and harms
      • 4.7.1 Mental health
      • 4.7.2 Social harms
  • 5 Cannabis
    • 5.1 Key findings
    • 5.2 Introduction
    • 5.3 Attitudes and opportunity to use
    • 5.4 Reported consumption
      • 5.4.1 Trends
      • 5.4.2 Characteristics of recent cannabis users
      • 5.4.3 Place of use
      • 5.4.4 Attempts to reduce use
    • 5.5 State and territory comparisons
    • 5.6 Health and harms
      • 5.6.1 Self-reported health status of cannabis users
      • 5.6.2 Psychological distress
    • 5.7 Recent use of cannabis among population sub-groups
      • Use among ecstasy and related drug users
      • Use among injecting drug users
      • Use among prisoners
      • Use among police detainees
    • 5.8 Supply reduction
  • 6 Illicit drugs other than cannabis
    • 6.1 Key findings
    • 6.2 Introduction
    • 6.3 Attitudes and opportunity to use
      • 6.4.1 Any illicit drug, excluding cannabis
      • 6.4.2 Ecstasy use
      • 6.3.1 Meth/amphetamine use
      • 6.3.2 Cocaine use
      • 6.3.3 Use of other illicit drugs
      • 6.3.4 Frequency of use
    • 6.5 Social characteristics
    • 6.6 State and territory comparisons
    • 6.7 Illicit drugs and health
      • 6.3.5 Mortality
      • 6.3.6 Non-fatal overdoses
      • 6.3.7 Self-reported health status
        • Health conditions including mental illness
      • 6.3.8 Injecting drug use and health
  • 7 Pharmaceuticals
    • 7.1 Key findings
    • 7.2 Introduction
      • 7.2.1 Data sources
    • 7.3 Prescription medicines
      • 7.3.1 Prescribing patterns of general practitioners
      • 7.3.2 Volume
      • 7.3.3 Cost to the Australian Government
      • 7.3.4 Defined daily dose
    • 7.4 Community prescriptions for major drug groups
    • 7.5 Pharmaceutical misuse
      • 7.5.1 How are pharmaceuticals diverted?
      • 7.5.2 Pharmaceutical misuse among the general population
        • Use of pharmaceuticals for non-medical purposes
        • Frequency of use
        • Source of supply
      • 7.5.3 Use among police watch-house detainees
      • 7.5.4 Use among prisoners
  • 8 Aboriginal and Torres Strait Islander people
    • 8.1 Key findings
    • 8.2 Introduction
    • 8.3 Data sources
    • 8.4 Tobacco
      • 8.4.1 Attitudes
      • 8.4.2 Current use
      • 8.4.3 Trends
      • 8.4.4 Age and sex
      • 8.4.5 Indigenous and non-Indigenous comparisons
      • 8.4.6 Cessation behaviour
    • 8.5 Alcohol
      • 8.5.1 Current use
      • 8.5.2 Trends
      • 8.5.3 Age and sex
      • 8.5.4 Indigenous and non-Indigenous comparisons
      • 8.5.5 Cessation behaviours
    • 8.6 Illicit drugs
      • 8.6.1 Current use
      • 8.6.2 Age and sex
      • 8.6.3 Comparisons with other Australians
      • 8.6.4 Cessation behaviours
    • 8.7 Health and harms
      • 8.7.1 Morbidity and mortality
      • 8.7.2 Self-reported health status
      • 8.7.3 Drug use issues managed by general practitioners
      • 8.7.4 Passive smoking
      • 8.7.5 Mental health
      • 8.7.6 Injecting drug use
      • 8.7.7 Other harms
  • 9 Life stages
    • 9.1 Key findings
    • 9.2 Introduction
    • 9.3 School students
      • 9.3.1 Tobacco use
      • 9.3.2 Alcohol use
      • 9.3.3 Illicit drug use
    • 9.4 Employment and workforce participation
      • 9.4.1 Smoking status
      • 9.4.2 Alcohol use patterns
        • Alcohol risk
      • 9.4.3 Illicit drug use
      • 9.4.4 Drug use among employed people
    • 9.5 Pregnancy
      • 9.5.1 Smoking during pregnancy
      • 9.5.2 Other drug use during pregnancy
    • 9.6 Families
      • 9.6.1 Smoking status
      • 9.6.2 Exposure to environmental tobacco smoke
      • 9.6.3 Alcohol risk and families
      • 9.6.4 Illicit drug use
  • 10 Services
    • 10.1 Key findings
    • 10.2 Introduction
    • 10.3 Alcohol and other drug treatment
    • 10.4 Treatment agencies
    • 10.5 Treatment clients
    • 10.6 What drugs are clients concerned about?
      • 10.6.1 Trends
      • 10.6.2 Age and sex
      • 10.6.3 Injecting drug use
    • 10.7 What treatment do clients receive?
      • Counselling
      • Withdrawal management (detoxification)
      • Rehabilitation
      • Assessment only
      • Information and education only
      • Support and case management only
      • Other
    • 10.8 Current treatment and trends
      • 10.8.1 Age and sex
    • 10.9 Referral sources and cessation reasons
      • 10.9.1 Referral
      • 10.9.2 Reasons for cessation
    • 10.10 Other alcohol and drug treatment data
      • 10.10.1 Opioid substitute pharmacotherapy
      • 10.10.2 Indigenous services
      • 10.10.3 Needle and syringe programs
      • 10.10.4 Survey data
    • 10.11 Other services that may assist people with alcohol and other drug issues
      • 10.11.1 GP visits
      • 10.11.2 Hospital treatment (morbidity)
      • 10.11.3 Homelessness services
      • 10.11.4 Mental health services
  • 11 Crime and law enforcement
    • 11.1 Key findings
    • 11.2 Introduction
    • 11.3 Illicit drug offences
      • 11.3.1 Illicit drug arrests
      • 11.3.2 Prison census statistics
    • 11.4 Drug use and criminal offending
      • 11.4.1 Drug use among police detainees
    • 11.5 Prisoners' self-reported drug use
      • 11.5.1 Tobacco
      • 11.5.2 Drug use among juvenile detainees
        • Prevalence of drug use
        • Frequency of drug use
        • Substance use and crime
    • 11.6 Self-reported crime by injecting drug users
    • 11.7 Illicit drug purity and detections
      • 11.7.1 Purity of illicit drugs
      • 11.7.2 Australian border detections of illicit drugs
        • Border detections of heroin
        • Border detections of amphetamine-type stimulants
        • Cannabis border detections
      • 11.7.3 Australian domestic drug detection
        • Detection of drug laboratories
        • Cannabis detections
• End matter
  • Appendix A - Poisons Standard Schedule categories
  • References
  • List of tables
  • List of figures